These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38791230)

  • 1. Protein Citrullination by Peptidyl Arginine Deiminase/Arginine Deiminase Homologs in Members of the Human Microbiota and Its Recognition by Anti-Citrullinated Protein Antibodies.
    Pérez-Pérez ME; Nieto-Torres E; Bollain-Y-Goytia JJ; Delgadillo-Ruíz L
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
    Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
    Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
    Li B; Li P; Bi L
    Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
    Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
    Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
    Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
    J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
    Curran AM; Naik P; Giles JT; Darrah E
    Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
    Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
    Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the study and origin of the citrullinome in rheumatoid arthritis.
    Fert-Bober J; Darrah E; Andrade F
    Immunol Rev; 2020 Mar; 294(1):133-147. PubMed ID: 31876028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of membranolytic targeting and intracellular citrullination in neutrophils isolated from patients with rheumatoid arthritis.
    Moadab F; Wang X; Le E; Gazitt T; Najjar R; Nelson JL; Joshua V; Malmström V; Elkon K; Grönwall C; Mustelin T
    Sci Rep; 2024 Jul; 14(1):15511. PubMed ID: 38969707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
    Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
    Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
    Wang Y; Chen R; Gan Y; Ying S
    Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
    Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
    Front Immunol; 2021; 12():716250. PubMed ID: 34737738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
    Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
    Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
    Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
    Front Immunol; 2018; 9():3033. PubMed ID: 30662440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
    Darrah E; Rosen A; Giles JT; Andrade F
    Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
    Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
    Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis.
    Yu K; Dillemans L; Gouwy M; Bessa H; Metzemaekers M; Martens E; Matthys P; Bossuyt X; Verschueren P; Wouters C; De Somer L; Proost P
    Front Immunol; 2023; 14():1111465. PubMed ID: 36793709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment.
    Mansouri P; Mansouri P; Behmard E; Najafipour S; Kouhpayeh SA; Farjadfar A
    Int J Biol Macromol; 2024 Oct; 278(Pt 3):134576. PubMed ID: 39127273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
    Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
    J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.